supplementary tables.docx (16.48 kB)

Supplementary tables.docx: PD-L1 Testing and Clinical Management of Newly Diagnosed Metastatic Non-Small Cell Lung Cancer in Spain: MOREL study

dataset

posted on 2021-11-30, 02:28 authored by Belen Rubio-Viqueira, M Majem, Martin Lazaro, Sergio Vazquez, Juan Cordoba Ortega, Inmaculada Maestu Maiques, Jorge Garcia-Gonzalez, Ana Blasco, Javier Valdivia, Carmen Gonzalez-Arenas, Jose Sanchez-Torres

Supplementary Table 1. Systemic treatment: Characterization and description.

Supplementary Table 2. PD-L1 expression by clinico-pathological characteristics.

Funding

This study was funded by MSD Spain

History

Usage metrics

Read the peer-reviewed publication

PD-L1 Testing and Clinical Management of Newly Diagnosed Metastatic Non-Small Cell Lung Cancer in Spain: MOREL study

Lung Cancer Management

Keywords

Non-small cell lung cancer advanced or metastatic first line treatment immunotherapy PD-L1 expression Cancer Diagnosis

Licence

CC BY-NC-ND 4.0